Global Innovative Platforms (GIPL) updates investor presentation

Rhea-AI Filing Summary

Global Innovative Platforms Inc. furnished an updated investor presentation and posted it on its website on September 26, 2025. The presentation, which outlines information for current and potential investors, is available under the Investor Relations section of www.vetbreath.com and is also provided as Exhibit 99.1 to a current report. The materials are being shared for informational purposes and are designated as furnished rather than filed under securities laws.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001837774 0001837774 2025-09-26 2025-09-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION

 WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

 The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 26, 2025

Global Innovative Platforms Inc.

 (Exact name of registrant as specified in its charter)

Delaware	000-56235	85-3816149
(State of other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

149 James Place, Maitland, Florida 32751

 (Address of principal executive office)

321-230-3739

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
		None

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On September 26, 2025, Global Innovative Platforms Inc. (the “Company”) posted an updated investor presentation on its website. A copy of the Company’s presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01. The presentation will be made available on the Company’s website at www.vetbreath.com under Investor Relations. The information contained on the Company’s website shall not be deemed part of this Current Report on Form 8-K.

The information contained in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent expressly stated in such filing.

Item 9.01.  Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number	Description
99.1	Investor Presentation in use beginning September 26, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

September 26, 2025	Global Innovative Platforms Inc.
	/s/ Andrew Brown
	Name: Andrew Brown
	Title: Chief Executive Officer and Chief Financial Officer

FAQ

What did Global Innovative Platforms Inc. (GIPL) disclose in this 8-K?

Global Innovative Platforms Inc. furnished an updated investor presentation and made it available on its website, also attaching it as Exhibit 99.1 to a current report.

Where can investors find Global Innovative Platforms Inc. (GIPL)'s new investor presentation?

The updated presentation is available on the company’s website at www.vetbreath.com under the Investor Relations section and is included as Exhibit 99.1.

When did Global Innovative Platforms Inc. (GIPL) begin using the updated investor presentation?

The investor presentation is described as being in use beginning September 26, 2025.

Is the Global Innovative Platforms Inc. (GIPL) investor presentation considered filed with the SEC?

No. The company states the information in the current report, including Exhibit 99.1, is being furnished and is not deemed filed for purposes of Section 18 of the Exchange Act.

Does the Global Innovative Platforms Inc. (GIPL) investor presentation become part of other SEC filings automatically?

The company notes the information, including Exhibit 99.1, will not be incorporated by reference into other Securities Act or Exchange Act filings unless expressly stated in those filings.

Who signed the Global Innovative Platforms Inc. (GIPL) current report containing the investor presentation?

The report was signed on behalf of the company by Andrew Brown, its Chief Executive Officer and Chief Financial Officer, on September 26, 2025.